Status:
COMPLETED
Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?
Lead Sponsor:
University of Aarhus
Conditions:
Vitamin B12 Deficiency
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Vitamin B12 is an essential nutrient for normal DNA-synthesis and must be supplied by animal products. Vitamin B12 deficiency may cause anemia and irreverible neurological damage. Laboratory tests are...
Detailed Description
Vitamin B12 is an essential nutrient for normal DNA-synthesis and must be supplied by animal products. Vitamin B12 deficiency may cause anemia and irreverible neurological damage. Laboratory tests are...
Eligibility Criteria
Inclusion
- Patients suspected to have vitamin B12 deficiency defined as a plasma vitamin B12 below the reference interval (\<200 pmol/L).
Exclusion
- Patients who were pregnant, nursing or not able to give written informed consent were excluded.
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT00279552
Start Date
April 1 2004
End Date
December 1 2004
Last Update
January 19 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department for Clinical Biochemistry
Aarhus, Denmark, 8000